Admedus" CardioCell biomaterial scaffold technology validated by independent peer-reviewed study - Proactive Investors Australia

Admedus" CardioCell biomaterial scaffold technology validated by independent peer-reviewed study  Proactive Investors AustraliaAdmedus Ltd (ASX:AHZ) has had its CardioCel transcatheter aortic valve replacement (TAVR) devices validated through the publication of an independent study ...